NOKANG NKD (NUOKANG BIOTECH)

Xiamen Nuokang Biotechnology Co., Ltd. is the world's leading new drug research and development company for carbohydrate biochemistry cell therapy. Nokang has focused on macrophage, NK cell new immunological checkpoint inhibitor research, and based on non-viral cell therapy (CECT), has achieved a series of exciting results.